Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities

Patients with locally advanced colorectal cancer (LACRC) have a high risk of recurrence and metastasis, although neoadjuvant therapy may provide some benefit. However, patients with high microsatellite instability/deficient mismatch repair (MSI-H/dMMR) LACRC receive little benefit from neoadjuvant c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xuan, Wu, Tao, Cai, Xinyi, Dong, Jianhua, Xia, Cuifeng, Zhou, Yongchun, Ding, Rong, Yang, Renfang, Tan, Jing, Zhang, Lijuan, Zhang, Ya, Wang, Yuqin, Dong, Chao, Li, Yunfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968082/
https://www.ncbi.nlm.nih.gov/pubmed/35371084
http://dx.doi.org/10.3389/fimmu.2022.795972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968082/
https://www.ncbi.nlm.nih.gov/pubmed/35371084
http://dx.doi.org/10.3389/fimmu.2022.795972

Ejemplares similares